Skip to main content
Laura Calvi, MD, Endocrinology, Rochester, NY

LauraMCalviMD

Endocrinology Rochester, NY

Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology

Associate Professor of Medicine, University Rochester

Dr. Calvi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Calvi's full profile

Already have an account?

  • Office

    601 Elmwood Ave
    # 320
    Rochester, NY 14642
    Phone+1 585-275-2901
    Fax+1 585-273-1288

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1995 - 1998
  • Harvard Medical School
    Harvard Medical SchoolClass of 1995

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2025
  • MA State Medical License
    MA State Medical License 2000 - 2002

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • 585 Magazine Castle Connolly, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Abstracts/Posters

  • Local Irradiation Induces Systemic Inflammatory Response and Alteration of the Hematopoietic Stem Cell Niche
    Laura M. Calvi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Specific Mesenchymal Stem and Progenitor Cell (MSPC) Subpopulation with a Multi-Potent Gene Signature Is Transcriptionally Altered in the Setting of Myelodysplastic ...
    Laura M. Calvi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Wilmot Cancer Institute Secures $13.6 Million in Grants
    Wilmot Cancer Institute Secures $13.6 Million in GrantsAugust 8th, 2022
  • Named Positions Celebrate the Work of Rochester’s Faculty
    Named Positions Celebrate the Work of Rochester’s FacultyFebruary 8th, 2021
  • Delving Where Few Others Have Gone, Leukemia Researchers Open New Path
    Delving Where Few Others Have Gone, Leukemia Researchers Open New PathOctober 15th, 2018

Grant Support

  • Hematopoietic-Osteoblastic InteractionsNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2012
  • Bone Marrow - Mitigation Of Bone Marrow Radiation InjuryNational Institute Of Allergy And Infectious Diseases2010–2011
  • Regulatory Cell Signals In The Bone MarrowNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Roles Of Pth/Pthrp Receptors In Osteoblastic CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
  • Osteoblastic Activation In The Hematopoietic Stem CellNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
  • Roles Of Pth/Pthrp Receptors In OsteoblastsNational Institute Of Diabetes And Digestive And Kidney Diseases2001